A computer model developed by researchers from Japan and Seattle's Allen Institute could lead to new methods for studying ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results